- Home
- KREF vs AMLX Comparison
KREF vs AMLX Comparison
Compare KREF & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KREF
- AMLX
- Stock Information
- Founded
- KREF 2014
- AMLX 2014
- Country
- KREF United States
- AMLX United States
- Employees
- KREF N/A
- AMLX N/A
- Industry
- KREF Real Estate Investment Trusts
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- KREF Real Estate
- AMLX Health Care
- Exchange
- KREF Nasdaq
- AMLX Nasdaq
- Market Cap
- KREF 593.7M
- AMLX 684.6M
- IPO Year
- KREF 2017
- AMLX 2022
- Fundamental
- Price
- KREF $9.07
- AMLX $7.72
- Analyst Decision
- KREF Buy
- AMLX Strong Buy
- Analyst Count
- KREF 7
- AMLX 7
- Target Price
- KREF $12.32
- AMLX $12.00
- AVG Volume (30 Days)
- KREF 722.5K
- AMLX 1.5M
- Earning Date
- KREF 07-22-2025
- AMLX 08-07-2025
- Dividend Yield
- KREF 11.03%
- AMLX N/A
- EPS Growth
- KREF N/A
- AMLX N/A
- EPS
- KREF N/A
- AMLX N/A
- Revenue
- KREF $40,393,000.00
- AMLX N/A
- Revenue This Year
- KREF $27.61
- AMLX N/A
- Revenue Next Year
- KREF N/A
- AMLX N/A
- P/E Ratio
- KREF N/A
- AMLX N/A
- Revenue Growth
- KREF N/A
- AMLX N/A
- 52 Week Low
- KREF $8.28
- AMLX $1.76
- 52 Week High
- KREF $12.95
- AMLX $8.72
- Technical
- Relative Strength Index (RSI)
- KREF 48.63
- AMLX 54.70
- Support Level
- KREF $9.00
- AMLX $7.84
- Resistance Level
- KREF $9.33
- AMLX $8.29
- Average True Range (ATR)
- KREF 0.24
- AMLX 0.45
- MACD
- KREF 0.00
- AMLX -0.13
- Stochastic Oscillator
- KREF 66.08
- AMLX 2.90
About KREF KKR Real Estate Finance Trust Inc.
KKR Real Estate Finance Trust Inc is a real estate finance company that focuses on originating and acquiring senior mortgage loans secured by CRE assets. The investment is to originate or acquire senior mortgage loans collateralized by institutional-quality CRE assets that are owned and operated by experienced and well-capitalized sponsors and located in liquid markets with underlying fundamentals. KKR manages investments across multiple asset classes, including private equity, real estates, energy, infrastructure, credit, and hedge funds. The company's investment objective is capital preservation and generating attractive risk-adjusted returns for its stockholders over the long term, through dividends.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.